SETRON - ARE 5-HT(3) RECEPTOR ANTAGONISTS DIFFERENT

被引：10

作者：

AAPRO, MS

机构：

来源：

EUROPEAN JOURNAL OF CANCER | 1993年 / 29A卷 / 12期

关键词：

D O I：

10.1016/0959-8049(93)90097-Y

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1655 / 1655

页数：1

共 6 条

[1]

ANDREWS P L R, 1992, European Journal of Cancer, V28A, pS2, DOI 10.1016/0959-8049(92)90628-F

[2] STRATIFIED, RANDOMIZED, DOUBLE-BLIND COMPARISON OF INTRAVENOUS ONDANSETRON ADMINISTERED AS A MULTIPLE-DOSE REGIMEN VERSUS 2 SINGLE-DOSE REGIMENS IN THE PREVENTION OF CISPLATIN-INDUCED NAUSEA AND VOMITING [J].

BECK, TM ;

HESKETH, PJ ;

MADAJEWICZ, S ;

NAVARI, RM ;

PENDERGRASS, K ;

LESTER, EP ;

KISH, JA ;

MURPHY, WK ;

HAINSWORTH, JD ;

GANDARA, DR ;

BRICKER, LJ ;

KELLER, AM ;

MORTIMER, J ;

GALVIN, DV ;

HOUSE, KW ;

BRYSON, JC .

JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (12) :1969-1975

[3] THE BUDGETARY IMPACT OF 5-HT3 RECEPTOR ANTAGONISTS IN THE MANAGEMENT OF CHEMOTHERAPY-INDUCED EMESIS [J].

JONES, AL ;

LEE, GJ ;

BOSANQUET, N .

EUROPEAN JOURNAL OF CANCER, 1993, 29A (01) :51-56

[4] COMPARISON OF THE ANTIEMETIC EFFICACY OF DIFFERENT DOSES OF ONDANSETRON, GIVEN AS EITHER A CONTINUOUS INFUSION OR A SINGLE INTRAVENOUS DOSE, IN ACUTE CISPLATIN-INDUCED EMESIS - A MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PARALLEL GROUP-STUDY [J].

SEYNAEVE, C ;

SCHULLER, J ;

BUSER, K ;

PORTEDER, H ;

VANBELLE, S ;

SEVELDA, P ;

CHRISTMANN, D ;

SCHMIDT, M ;

KITCHENER, H ;

PAES, D ;

DEMULDER, PHM ;

LUDWIG, H ;

LENZHOFER, R ;

CHATELAIN, C ;

DAUBRESSE, M ;

FOCAN, C ;

HUYS ;

PARIDAENS, R ;

WEYNANTS, P ;

HANSEN, O ;

MATTSON, K ;

VERMORKEN, J ;

WILS, J ;

MAGNUSSON, K ;

ROBINSON, E ;

BRENNER, HJ ;

DICATO, M ;

DIAZRUBIO, E ;

GONZALEZBARON, DM ;

CUNNINGHAM, D ;

MORGAN, D ;

ROBERTS, T ;

BRUNTSCH, U ;

MEINECKE, H ;

OHL, S ;

RAETH, U ;

WESTERHAUSEN, M .

BRITISH JOURNAL OF CANCER, 1992, 66 (01) :192-197

[5]

TYERS MB, 1992, ONCOLOGY, V49, P263

[6]

1992, LANCET, V340, P96

← 1 →